TherapeuticsMD, Inc. - FORM 10-Q - EX-31.2 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER - May 19, 2011

Attached files

file filename
EX-10.3 - CONVERTIBLE PROMISSORY NOTE TO ENERGY CAPITAL - TherapeuticsMD, Inc.ex10-3.htm
EX-10.4 - SALES REPRESENTATION AGREEMENT - TherapeuticsMD, Inc.ex10-4.htm
EX-10.2 - CONVERTIBLE PROMISSORY NOTE - TherapeuticsMD, Inc.ex10-2.htm
EX-10.1 - PROMISSORY NOTE TO PHILIP M. COHEN - TherapeuticsMD, Inc.ex10-1.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE AND PRINCIPAL FINANCIAL OFFICER - TherapeuticsMD, Inc.ex31-1.htm
10-Q - QUARTERLY REPORT - TherapeuticsMD, Inc.amhn-10q_033111.htm
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the quarterly report of AMHN, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2011 as filed with the Securities and Exchange Commission (the “Report”), I, Jeffrey Howes, Principal Executive Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
 
 
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
/s/ Jeffrey Howes  
Jeffrey Howes   
Principal Executive Officer
Principal Financial Officer
May 19, 2011
 
A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
 
 
 
 

TherapeuticsMD, Inc. Reports

Also read